Article
Pioglitazone Hydrochloride Extends the Lifespan of Caenorhabditis elegans by Activating DAF‐16/FOXO‐ and SKN‐1/NRF2‐Related Signaling Pathways
1 Jan 2022
Abstract excerpt
Pioglitazone hydrochloride (PGZ), a nuclear receptor peroxisome proliferator‐activated receptor gamma (PPAR‐γ) agonist, is a universally adopted oral agent for the treatment of type 2 diabetes (T2D). Previous studies reported that PGZ could ameliorate the symptoms of aging‐related diseases and Alzheimer’s disease. However, whether PGZ participates in aging regulation and the underlying mechanism remain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
